Liberia documents
Annual progress reports
Countries no longer submit annual progress reports. Please refer to the joint appraisal report and Multi-Stakeholder Dialogue documents on this page.
Annual progress report Liberia 2007
Annual progress report Liberia 2014
Annual progress report Liberia 2006
Annual progress report Liberia 2013
Annual progress report Liberia 2004
Annual progress report Liberia 2012
Annual progress report Liberia 2005
Annual progress report Liberia 2011
Annual progress report Liberia 2003
Annual progress report Liberia 2010
Annual progress report Liberia 2002
Annual progress report Liberia 2009
Annual progress report Liberia 2001
Annual progress report Liberia 2008
The joint appraisal report and Multi-Stakeholder Dialogue
The joint appraisal is an in-country, multi-stakeholder review of the implementation progress and performance of Gavi's vaccine and cash grant support to the country, and of its contribution to improved immunisation outcomes. The outcome of the appraisal is the completed "joint appraisal report" that captures Gavi grant performance as well as implementation challenges. The joint appraisal report informs discussions with national coordination mechanisms on areas where greater national investments and efforts, as well as technical support, are needed.
In 2020/2021, as a result of the COVID-19 pandemic, Multi-stakeholder dialogue (MSD) documents temporarily replaced the traditional Joint Appraisal to ensure that Gavi’s continuing support to the EPI programme be aligned with realities at country level.
Approved proposals
All eligible countries are invited to submit proposals for Gavi support.
Proposal for NVS-YF diagnostics 2020: Liberia
Decision Letter Liberia IPV 2019
Decision Letter NVS Liberia 2017
Decision Letter NVS Liberia 2014(2)
Decision letter HSS Liberia 2012
Proposal for NVS Typhoid conjugate vaccine (2020): Liberia
Proposal for NVS - HPV routine and measles 1+2 routine support 2018 - Liberia
Proposal for NVS - measles follow-up campaign 2017 : Liberia
Proposal for PSR (HSS & CCEOP) Support 2017: Liberia
Proposal for NVS – IPV support
Proposal for NVS - Rota support: Liberia
Proposal for HPV Demo support: Liberia
Proposal for NVS - PCV support: Liberia
Proposal for HSS support: Liberia (2012)
Proposal for HSS support: Liberia
Proposal for ISS support: Liberia
Proposal for INS support: Liberia
Proposal for NVS - YF support: Liberia
Proposal for ISS support: Liberia (2000)
Comprehensive multi-year plans, Financial sustainability plans, National Immunisation Strategy
The comprehensive multi-year plan (cMYP) is a single plan which consolidates several immunisation activities. It is a key planning and management tool for national immunisation programmes. It addresses global, national, and subnational immunisation objectives and strategies, and evaluates the costs and financing of the programme in line with the WHO-UNICEF Global Immunization Vision and Strategy 2006-2015. Gavi requires countries to submit a cMYP along with the standard proposal form when applying for Gavi support (ISS, INS, and NVS). In 2006, over 50 countries had developed cMYPs using the WHO-UNICEF cMYP guidelines and costing tool.
The cMYP replaces the financial sustainability plan (FSP), used to assess the funding challenges of a country's national immunisation programme within the broader health financing context and to describe the government’s approach to mobilising and effectively using resources to support medium- and long-term immunisation objectives.
Country co-financing information sheet
The country-specific co-financing sheets provide up-to-date information on countries’ eligibility status, co-financing fulfilment and requirements. They also give a summary of government health expenditure, including immunisation financing.
Specifically, the sheets provide a history of the Gavi-supported vaccines introduced per country, the country’s co-financing payments to date and its co-financing requirements for the current year. In case the country has defaulted on its co-financing requirements, there is an overview of the co-financing arrears of the previous year. Finally, the sheets provide co-financing projections for the next five years based on our latest forecasts.
The information sheets are updated at least twice per year to account for new information on countries’ co-financing fulfilment (in the first quarter) and eligibility status (in the third quarter).
Co-financing information sheet Liberia
Data quality audit
The DQA has been developed by WHO to help evaluate the quality of countries' health information systems and to verify the accuracy of reported data. Read more.
DQAs/SFPs Liberia
Decision Letters and Partnerships Agreement
The Decision Letter or Partnership Framework Agreement provides a summary of the details of the new approval or continuation of a Gavi window of support, following the independent review of a new application or annual progress report submitted by a country.
Decision Letter MR Liberia 2023
Decision Letter COVID19 Liberia 2023
Decision Letter MAL Liberia 2023
Decision Letter YF Liberia 2022
Decision Letter TCV Liberia 2022
Decision Letter PENTA Liberia 2022
Decision Letter RV Liberia 2022
Decision Letter PCV Liberia 2022
Decision Letter MR Liberia 2022
Decision Letter IPV Liberia 2022
Decision Letter HPV Liberia 2022
Decision Letter M Liberia 2021
Decision Letter YF Liberia 2021
Decision Letter RV Liberia 2021
Decision Letter PENTA Liberia 2021
Decision Letter PCV Liberia 2021
Decision Letter IPV Liberia 2021
Decision Letter M Liberia 2020
Decision Letter RV Liberia 2020
Decision Letter PENTA Liberia 2020
Decision Letter PCV Liberia 2020
Decision Letter IPV Liberia 2020
Decision Letter HPV Liberia 2020
Decision Letter YF Liberia 2020
Decision Letter HSS Liberia 2020
Decision Letter M Liberia 2019
Decision Letter ISD Liberia 2019
Decision Letter IPV Liberia 2019
Decision Letter YF Liberia 2019
Decision Letter RV Liberia 2019
Decision Letter PENTA Liberia 2019
Decision Letter PCV Liberia 2019
Decision Letter HPV Liberia 2019
Decision Letter NVS Liberia 2017 (3)
Decision Letter NVS Liberia 2014(3)
Decision Letter Liberia IPV 2019
Decision Letter Devices Liberia 2017 (2)
Decision letter NVS Liberia 2014 (2)
Decision Letter NVS Liberia 2017
Decision Letter NVS Liberia 2017 (2)
Decision letter NVS Liberia 2014
Decision Letter NVS Liberia 2014(2)
Decision Letter Devices Liberia 2017
Decision letter NVS Liberia 2013(2)
Decision letter HSS Liberia 2012
Decision Letter CCEOP Liberia 2017
Partnership Framework Agreement Liberia
Decision Letter Liberia HSS 2019
Decision Letter HSS Liberia 2017(2)
Decision letter NVS Liberia 2013
Decision Letter Liberia ISD 2019
Decision Letter HSS Liberia 2017
Decision Letter NVS Liberia 2018
Decision letter Ebola Liberia 2015
HSS evaluation
The HSS evaluation team visited several countries (in depth country studies) and conducted a number of country desk reviews (Country desk studies).
HSS evaluation Liberia
COVAX Technical Assistance Plans
In September 2020, the Gavi Board approved resources from core funding to focus on urgent technical assistance (TA) needs for 92 AMC economies, for the planning and preparation for the introduction of the COVID-19 vaccine. The plan includes sets of activities, milestones and budget for a given year.
COVAX Technical Assistance Plan Liberia 2021
Targeted country assistance plans
Targeted country assistance (TCA) are resources provided to in-country partners under Gavi’s partners’ engagement framework (PEF). A country’s TCA plan is based on needs expressed by the country during the joint appraisal discussions. It includes sets of activities, milestones and budget for a given year.
Targeted Country Assistance Plan Liberia 2022
Targeted Country Assistance Plan Liberia 2021
Targeted Country Assistance Plan Liberia 2020
Targeted Country Assistance Plan Liberia 2019
Targeted country assistance plan Liberia 2018
Targeted country assistance plan Liberia 2017